pharmaceutical investing Neon Therapeutics Completes Enrollment in Phase 1b NT-002 Clinical Trial for Metastatic Non-Small Cell Lung Cancer
E-Power Resources Inc. Announces Closing of Oversubscribed Hard Dollar and Flow-through Private Placements
